Recent Articles from GlobeNewswire

DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- CMB Regional Centers (CMB) today announced the launch of CMB Group 103 – Atlanta Logistics, an EB-5 offering associated with the development of a Class-A logistics facility in the southeastern United States.

– Oral presentation to feature 99-patient dataset with extended follow-up in newly diagnosed NPM1-m or KMT2A-r AML –

Recognition validates Airia's unified approach to AI security, orchestration, and governance for legal enterprises

HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.®, a Skyward Group Company, (Nasdaq: SKWD) ("Skyward Specialty" or "the Company"), a leading provider in the specialty property and casualty (P&C) insurance market, announced the appointment of Melissa Goto as President, E&S Brokerage and Inland Marine, to spearhead the strategic development of these businesses.

WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the refinancing of its existing debt facility with a new $150 million debt facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”).

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced the launch of the 21shares Hyperliquid ETF (Ticker: THYP), providing direct spot exposure and integrating staking rewards, and the 21shares 2x Long HYPE ETF (Ticker: TXXH), offering leveraged exposure. The funds are the first U.S. ETFs designed to provide investors with exposure to HYPE, the native token of Hyperliquid, a next-generation decentralized exchange (DEX) that has emerged as a significant liquidity hub for 24/7 on-chain trading infrastructure.

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple programs in its hematology portfolio, including an oral presentation of data from the RALLY-MF phase 2 trial of DISC-0974 in anemia of myelofibrosis (MF), at the upcoming European Hematology Association (EHA) 2026 Congress, which will be held in Stockholm, Sweden on June 11-14, 2026.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced upcoming presentations on the BALLI-01 and NATHALI-01 clinical trials, at the European Hematology Association (EHA) annual congress, on June 11-14, 2026, in Stockholm, Sweden.

New York, NY, May 12, 2026 (GLOBE NEWSWIRE) -- South Street Securities Holdings Inc. (“South Street”) today announced that it acquired 100% of the outstanding equity in Lime Funding, LLC (“Lime Funding”) on February 28, 2026. Lime Funding is an asset‑backed commercial paper (“ABCP”) conduit designed to make loans to corporate and other institutional borrowers, with funding provided through the issuance of ABCP to investors.

BERKELEY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for oral presentations at the 2026 European Hematology Association (EHA) Annual Meeting, which will be held June 11-14, 2026, in Stockholm, Sweden.

CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated biomarker data from the BEACON Phase 1/2 clinical trial of ristoglogene autogetemcel (risto-cel) in sickle cell disease (SCD) at the European Hematology Association 2026 Congress (EHA2026), taking place June 11-14, 2026, in Stockholm, Sweden. Risto-cel is an investigational autologous cell therapy with a potential best-in-class profile for the treatment of SCD.

Treatment with BH-30236, a novel CLK inhibitor, was generally well tolerated as monotherapy and in combination with venetoclax

LITTLE ROCK, Ark., May 12, 2026 (GLOBE NEWSWIRE) -- Uniti Wholesale’s FastWaves™ demonstrated momentum just two weeks after launch. The company signed a new customer for eight 400G circuits and delivered FastWaves™-eligible circuits in 14 days — early evidence of demand for faster wavelength delivery.

PayZen’s State of Healthcare Affordability: The Provider Perspective 2026 report highlights rising focus on better financial experiences, limited payment flexibility, and AI acceleration

New AI-powered mobile threat protection, expanded threat intelligence, and Concierge experience enhancements help organizations reduce risk across an increasingly distributed attack surface

Purpose-built program designed specifically for eligible Huntress customers and partners to help reduce cyber risk and simplify access to cyber insurance coverage

New solution reveals $3.78 spent per person on average for at-home dinners; top retailers have $100 million opportunity with Purchase to Consumption insights

SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences:

Winners are nurse leaders whose work focuses on mentorship for new nurses, neonatal care and education, and better perioperative care team communication

The podcast provides educational, experience-based insights into selling home service-based businesses, with guidance on valuations, transactions, and operational readiness

Co-developed with leading private markets firms, Ontra’s solution delivers the speed, accuracy, and consistency investor diligence demands

New ‘AI Sommelier’ Pairs ChatGPT, Customer Insights, and Inventory Data to Deliver Highly Personalized Recommendations for Wine Collectors and Enthusiasts

Delivers industry’s fastest performance capability with 1-gamma DRAM and advanced packaging

New exposure management capabilities unify vulnerability and attack surface insights to help prioritize and reduce real-world cyber risk

New platform enhancements for complex environments include Signal Intelligence, Persistent Context and Cross-domain Investigations

New program delivers a preemptive, evidence-backed approach for reducing risk and continuously validating control effectiveness

ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Soaring, a leader in autonomous aerial logistics for contested environments, today announced its participation in the U.S. Army XVIII Airborne Corps 44th Medical Brigade’s field training exercise focused on autonomous Class VIII (medical) resupply. Over several months, Soaring worked with the 44th Medical Brigade to plan and coordinate the validation effort, evaluating how unmanned aerial systems (UAS) can extend logistics in dispersed and contested environments where speed and access directly impact survivability.

mpathic launches mPACT, a clinician-led benchmark for evaluating how AI models perform in high-risk scenarios, including suicide risk, eating disorders, and with misinformation.

LIMASSOL, Cyprus, May 12, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE), (“Robin”, or the “Company”), an international ship-owning company providing energy transportation services globally, today announced its results for the three months ended March 31, 2026.

BulkQuant has officially launched its new AI-powered quantitative trading platform, introducing an advanced automated trading solution designed for investors seeking smarter portfolio management, passive income opportunities, and data-driven market execution.

LiveWorld continues to increase its AI investment

The Human Side of Autonomous Mobility, by field operator and mobility executive Carlo Iacovini, delivers a direct challenge to the AI-first narrative: as robotaxi volumes surge and safety investigations multiply in the same week, the industry's real bottleneck has never been the algorithm

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced new research highlighting growing advertiser adoption of AI-powered solutions and increasing interest in applying these capabilities beyond walled gardens.

SAN FRANCISCO, May 12, 2026 (GLOBE NEWSWIRE) -- Today, Opendoor Technologies Inc. (“Opendoor”) (Nasdaq: OPEN) announced that Kaz Nejatian, Chief Executive Officer, will present at the following investor conference:

Funding through MDA Care Advance Grant program supports Stanford Health Care and the University of Minnesota

State of Identity Security 2026 report finds human error and poor non-human identity management are the root causes of most attacks, as agentic AI accelerates the risk

The integration also brings forth best-in-class authenticity and moderation against AI-driven fraud risk

GoGuardian Beacon's Active Planning Alerts achieves international certification for AI governance, demonstrating responsible design and development practices that build trust with school leaders and communities

ProVue Lung blood test detects lung cancers with 89% overall sensitivity and 83% sensitivity at stage I, the earliest and most treatable stage

– Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of pre-specified interim analysis –

Hong Kong and the Netherlands are among the 20 easiest jurisdictions

Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors

SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) today announced two new features for small and medium sized business customers in the US: Bulk Payments and Send by Link. At the same time, Remitly Business has reached general availability in Canada, joining the US and UK as the offering’s third live market.

State of Accounting 2026 finds accountants embracing AI and automation—yet disconnected systems and inefficient processes continue to limit productivity and consistent client experiences

SMITHFIELD, Va., May 12, 2026 (GLOBE NEWSWIRE) -- Smithfield Foods released its 24th annual sustainability report highlighting the company’s continued progress in animal care, environmental stewardship, food safety and community support.

Amazon, New York Life, Intuit and others use Vapi’s API-native enterprise voice AI platform for building, deploying, and managing voice agents at scale.

The first platform purpose-built for the layer beneath every customer interaction, serving restaurants, retail, and consumer brands from regional operators to global enterprises

New solution gives organizations a centralized view of AI usage, costs, and governance across tools, models, and teams

COLUMBIA, Md., May 12, 2026 (GLOBE NEWSWIRE) -- Tenable® Holdings, Inc. (NASDAQ: TENB), the exposure management company, today announced that Co-CEO Mark Thurmond and CFO Matt Brown will present at the J.P. Morgan Global Technology, Media and Communications Conference. Co-CEO Steve Vintz and Matt Brown will present at the William Blair Growth Stock Conference.

Lehi, Utah, May 12, 2026 (GLOBE NEWSWIRE) -- DigiCert, a global leader in intelligent trust, today announced it has been awarded the Frost & Sullivan 2026 Global Competitive Strategy Leadership Recognition in the Global DNS Security Industry. DigiCert earned this recognition for leading a strategic shift by unifying DNS and PKI within the DigiCert ONE platform, transforming infrastructure into an active layer of security, trust, and control.  

Cycode builds on the Complete Platform with the launch of ADLC Security, providing unmatched visibility, guardrails, and governance

Agentic Integration company also promotes Anjana Kashyap to Chief Customer Officer, Cassie Capano to Chief People Officer

IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Dave Haan as Vice President of Clinical Affairs. Dave will lead the company's clinical affairs strategy, overseeing the continued execution of JenaValve's clinical programs — including the ARTIST randomized controlled trial and the JENA-VAD Registry. His appointment strengthens the company’s clinical leadership during a pivotal period of organizational growth and commercial expansion following the recent FDA approval of the Trilogy THV System for symptomatic, severe aortic regurgitation (ssAR).

Awards celebrate outstanding contributions and commitment to customer success with exposure management

DAVIDSON, N.C. and PLYMOUTH, Mich. and ROLLE, Switzerland, May 12, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial and life science solutions and Garrett Motion (Nasdaq: GTX), a global leader in differentiated turbocharging and electrification technologies for mobility and industrial applications, today announced a multiyear strategic partnership to develop next generation oil-free air technologies designed to deliver greater energy efficiency, performance, and reliability for customers across key end markets, including food and beverage and life sciences.

FortiAIGate integration enables zero-trust AI environments with high-performance, GPU-accelerated security across any deployment model

Certification reinforces DP World’s end-to-end supply chain capabilities, advancing regional air freight connectivity and global compliance standards

New Facility Adds Service Capacity To Support Rapid Growth

The Vasco Translator M4 prioritizes ease of use with its intuitive one-button operation and guaranteed lifetime connectivity

DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Georgette Hunter-Franklin, MODE Global’s director of vendor relations and learning, has been awarded the esteemed OnCon Icon Top 10 Learning & Development Professional Award. The OnCon Icon Awards celebrate outstanding achievements of top organizations and executives globally who excel in their respective professional fields.

ARLINGTON, Va., May 12, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced the commencement of an underwritten public offering of an aggregate of 20,000,000 shares of its Class A common stock by certain controlling stockholders of Fluence. The selling stockholders are expected to grant the underwriters a 30-day option to purchase an additional 3,000,000 shares of Class A common stock on the same terms and conditions. Fluence is not selling any of its shares of Class A common stock in the offering and will not receive any of the proceeds from the sale of shares by the selling stockholders.

Vancouver, Canada, May 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that two additional participants have been successfully dosed in the fourth cohort of its FDA-approved Phase I/IIa clinical trial evaluating CMND-100 (MEAI) for the treatment of moderate to severe Alcohol Use Disorder (AUD).

PHILADELPHIA , May 12, 2026 (GLOBE NEWSWIRE) --

Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapies

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results

Appointment Strengthens Execution Leadership as BlockchAIn Advances Conversion into Purpose Built AI and HPC Data Center Capacity

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

A 25,000 Activation Pilot to Test Monetizing SurgePays' Subprime Customer Base. 

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced an update to the overall clinical and regulatory timeline for the BACKBEAT Trial evaluating Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) in pacemaker-indicated patients with uncontrolled hypertension despite medications. The Company is targeting completion of enrollment by the end of the third quarter of 2026. Further, the Company and Medtronic, its strategic collaborator for the BACKBEAT Trial and the commercialization of AVIM Therapy for the treatment of uncontrolled hypertension in patients indicated for a pacemaker, plan to submit the primary endpoint data for a late-breaking clinical trial presentation at a major cardiovascular conference in the second quarter of 2027. Lastly, assuming primary safety and efficacy endpoints are met, Medtronic plans to submit a marketing application for FDA approval after primary endpoint data analyses and reports are complete, and subsequently to pursue global regulatory approvals.

DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) today announced the promotion of Jeff Underwood to Executive Vice President, in recognition of his outstanding leadership and his commitment to excellence in executing our long-term growth strategy. Mr. Underwood will continue to serve as General Manager of Contractor Solutions.

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.